Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹136Cr
Rev Gr TTM
Revenue Growth TTM
-0.60%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

POLSON
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 9.3 | 6.1 | 14.4 | 22.6 | 21.6 | -16.7 | -4.9 | 11.3 | 2.7 | -4.7 | 1.9 | -2.1 |
| 16 | 25 | 19 | 16 | 21 | 21 | 17 | 19 | 21 | 20 | 18 | 18 |
Operating Profit Operating ProfitCr |
| 18.3 | 16.5 | 16.5 | 20.3 | 12.8 | 16.2 | 17.4 | 16.3 | 14.8 | 15.9 | 16.5 | 16.7 |
Other Income Other IncomeCr | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| 2 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 172.6 | 11.0 | 33.7 | 250.0 | -67.5 | -29.2 | -6.5 | -10.7 | 154.6 | -14.0 | 6.1 | -3.2 |
| 8.5 | 6.8 | 5.5 | 6.9 | 2.3 | 5.8 | 5.4 | 5.5 | 5.6 | 5.2 | 5.7 | 5.5 |
| 141.2 | 168.4 | 102.9 | 116.3 | 45.5 | 119.3 | 95.8 | 104.0 | 116.9 | 102.3 | 101.9 | 101.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 7.1 | 0.2 | 4.0 | -2.3 | 3.0 | -11.2 | -8.4 | 10.1 | -14.0 | 14.9 | -3.2 | -1.3 |
| 92 | 89 | 89 | 87 | 93 | 80 | 73 | 82 | 70 | 81 | 78 | 77 |
Operating Profit Operating ProfitCr |
| 11.9 | 14.5 | 17.6 | 17.4 | 14.9 | 17.1 | 17.6 | 15.9 | 17.0 | 16.4 | 16.1 | 15.9 |
Other Income Other IncomeCr | 7 | 22 | 7 | 10 | 6 | 5 | 4 | 3 | 3 | 1 | 2 | 2 |
Interest Expense Interest ExpenseCr | 8 | 9 | 7 | 7 | 7 | 7 | 6 | 4 | 6 | 4 | 4 | 4 |
Depreciation DepreciationCr | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 6 |
| 10 | 25 | 16 | 18 | 11 | 10 | 9 | 9 | 7 | 7 | 7 | 7 |
| 3 | 9 | 6 | 7 | 1 | 3 | 1 | 2 | 2 | 2 | 2 | 2 |
|
| 128.1 | 146.7 | -36.1 | 5.7 | -9.0 | -28.5 | 20.2 | -27.0 | -22.5 | 7.6 | 0.7 | -3.3 |
| 6.3 | 15.5 | 9.5 | 10.3 | 9.1 | 7.3 | 9.6 | 6.4 | 5.8 | 5.4 | 5.6 | 5.5 |
| 545.0 | 1,346.0 | 860.0 | 909.5 | 827.3 | 591.5 | 711.0 | 519.1 | 402.5 | 433.1 | 435.9 | 422.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 45 | 61 | 69 | 80 | 90 | 96 | 104 | 111 | 116 | 121 | 126 | 128 |
Current Liabilities Current LiabilitiesCr | 73 | 41 | 45 | 40 | 40 | 38 | 31 | 52 | 39 | 36 | 27 | 24 |
Non Current Liabilities Non Current LiabilitiesCr | 61 | 51 | 50 | 59 | 52 | 50 | 36 | 29 | 26 | 23 | 35 | 37 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 61 | 48 | 53 | 66 | 65 | 60 | 42 | 53 | 45 | 40 | 36 | 39 |
Non Current Assets Non Current AssetsCr | 120 | 107 | 111 | 114 | 117 | 124 | 130 | 139 | 136 | 140 | 153 | 151 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 19 | 35 | 19 | 6 | 11 | 32 | 22 | 2 | 12 | 25 | 17 |
Investing Cash Flow Investing Cash FlowCr | -46 | 0 | -9 | -11 | 0 | -22 | 3 | -9 | 0 | -10 | -19 |
Financing Cash Flow Financing Cash FlowCr | 23 | -34 | -11 | 5 | -12 | -10 | -25 | 10 | -15 | -15 | 2 |
|
Free Cash Flow Free Cash FlowCr | -37 | 30 | 18 | 4 | 4 | 20 | 13 | -12 | 11 | 16 | -3 |
| 292.1 | 217.2 | 187.4 | 56.2 | 112.3 | 447.0 | 262.7 | 24.7 | 252.0 | 488.3 | 328.8 |
CFO To EBITDA CFO To EBITDA% | 155.0 | 232.4 | 101.4 | 33.3 | 68.8 | 191.5 | 143.3 | 9.9 | 85.3 | 160.5 | 114.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 73 | 88 | 133 | 181 | 131 | 83 | 110 | 133 | 120 | 152 | 144 |
Price To Earnings Price To Earnings | 11.2 | 5.5 | 12.9 | 16.5 | 13.2 | 11.7 | 12.9 | 21.3 | 24.8 | 29.2 | 27.5 |
Price To Sales Price To Sales | 0.7 | 0.8 | 1.2 | 1.7 | 1.2 | 0.9 | 1.2 | 1.4 | 1.4 | 1.6 | 1.5 |
Price To Book Price To Book | 1.6 | 1.4 | 1.9 | 2.2 | 1.4 | 0.9 | 1.1 | 1.2 | 1.0 | 1.3 | 1.1 |
| 13.2 | 10.2 | 9.8 | 12.7 | 11.5 | 7.5 | 9.3 | 11.8 | 11.6 | 11.7 | 12.1 |
Profitability Ratios Profitability Ratios |
| 34.3 | 40.6 | 44.4 | 46.9 | 43.6 | 45.4 | 50.1 | 47.6 | 48.9 | 46.3 | 48.1 |
| 11.9 | 14.5 | 17.6 | 17.4 | 14.9 | 17.1 | 17.6 | 15.9 | 17.0 | 16.4 | 16.1 |
| 6.3 | 15.5 | 9.5 | 10.3 | 9.1 | 7.3 | 9.6 | 6.4 | 5.8 | 5.4 | 5.6 |
| 12.5 | 26.2 | 17.3 | 16.5 | 11.8 | 10.9 | 10.1 | 7.8 | 7.5 | 7.3 | 6.5 |
| 14.3 | 26.0 | 14.8 | 13.5 | 10.9 | 7.4 | 8.1 | 5.6 | 4.2 | 4.3 | 4.1 |
| 3.6 | 10.5 | 6.3 | 6.1 | 5.5 | 3.9 | 5.0 | 3.2 | 2.7 | 2.9 | 2.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Established in **1938** and operating as a subsidiary of **M/s AJI Commercial Private Limited**, Polson Limited is a pioneer in the specialty chemicals sector with a legacy dating back to **1906**. The company is recognized as **Asia’s largest manufacturer and exporter** of natural-based vegetable tannin extracts and eco-friendly leather chemicals.
Polson operates as a dominant supplier of Indian-origin eco-friendly chemicals to the international leather industry, maintaining a global footprint across more than **175 countries**. The company is listed on **BSE Limited** (since **July 03, 1995**) and maintains a lean capital structure with **1,20,000** equity shares and a paid-up capital of **Rs. 60,00,000**.
---
### **Specialized Product Portfolio & Industrial Applications**
The company operates within a single reportable segment: the manufacturing of **synthetic organic tanning substances**. However, its chemical formulations serve a diverse array of high-growth industries:
* **Leather Industry (Core):** Natural tannin materials and eco-friendly "effect chemicals" that meet stringent global quality and environmental standards.
* **Life Sciences & Consumer Goods:** Intermediates for **Pharmaceuticals**, **Agrochemicals**, food additives, fragrances, and surfactants.
* **Industrial & Performance Materials:** Specialized formulations for adhesives, sealants, advanced polymers, paints, coatings, and textile auxiliaries.
* **High-Tech & Infrastructure:** Chemicals for **Electronics** (conformal coatings), **Automotive** (performance coatings and tires), and **Construction** (surface treatments).
---
### **Operational Infrastructure & Circular Economy Integration**
Polson’s manufacturing strategy emphasizes cost optimization through sustainability and advanced maintenance protocols.
* **Waste-to-Energy Model:** The company utilizes a circular manufacturing process where residue from natural raw materials, such as **Hirda** and **Tamarind Testa**, is repurposed as **fuel for boilers**. This significantly reduces reliance on expensive **Furnace Oil**.
* **Manufacturing Footprint:** Operations are centered in **Kolhapur**, with a primary manufacturing unit at **5 Star MIDC, Kagal**, and a registered office in **Ambaghat**. Corporate functions are managed from **Mumbai**.
* **Operational Excellence:** The plant utilizes **SAP Plant Maintenance**, **FMEA** (Failure Mode & Effect Analysis), and **RCM** (Reliability Centered Maintenance) to ensure maximum uptime and reliability.
* **Energy Management:** A dedicated **'Energy Cell'** monitors consumption, though the manufacturing process is classified as **not energy-intensive**.
---
### **Research, Development & Import Substitution**
Innovation is a primary growth lever for Polson, driven by an in-house **Research Laboratory** staffed by industry professionals.
* **Strategic R&D Goals:** Focus is placed on creating high-purity, proprietary formulations to capture new clients and expand the product range in both domestic and international markets.
* **Cost Reduction:** Recent R&D breakthroughs have led to **advanced process derivations**, facilitating **import substitution** and lowering production costs.
* **Technology Independence:** The company relies exclusively on indigenous research; **no technology has been imported** in the last three years.
---
### **Strategic Growth Drivers & Macro Outlook**
Polson is positioned to benefit from the rapid expansion of the Indian specialty chemicals market, which is projected to reach **USD 41,256.1 Million by 2033**.
| Market Segment | Projected Value | Target Year | Growth Metric |
| :--- | :--- | :--- | :--- |
| **Global Specialty Chemicals** | **$1.29 Trillion** | **2034** | **3.66% - 5.7% CAGR** |
| **Indian Specialty Chemicals** | **$96.73 Billion** | **2034** | **4.41% CAGR** |
| **Global Leather Chemicals** | **$15 Billion** | **2030** | -- |
| **India's Global Market Share** | **$64 Billion** | **2025** | -- |
**Key Strategic Pillars:**
* **China+1 Strategy:** Capitalizing on the global shift to diversify supply chains away from China.
* **Government Incentives:** Leveraging **PLI Schemes** (offering **10-20% output incentives**) and the **RoDTEP Scheme** for export tax refunds.
* **Policy Alignment:** Adhering to **"Make in India"** and **"Atmanirbhar Bharat"** mandates to increase local content through **FY 25-26**.
* **Emerging Tech:** Exploring the integration of **AI, machine learning, and blockchain** for enhanced manufacturing traceability and efficiency.
---
### **Financial Performance & Capital Management**
The company has adopted a conservative financial stance, prioritizing debt reduction and capital preservation over immediate dividend payouts.
**Comparative Financial Highlights (Standalone):**
| Metric | FY 2023-24 (Rs. Lakhs) | FY 2022-23 (Rs. Lakhs) | FY 2021-22 (Rs. Lakhs) |
| :--- | :--- | :--- | :--- |
| **Total Turnover** | -- | **8,386** | **9,753** |
| **Net Profit** | -- | **499** | **642.12** |
| **Borrowings** | **3,475.72** | **4,606.46** | -- |
| **Trade Payables** | **1,038.13** | **550.63** | -- |
**Financial Strategy Observations:**
* **Deleveraging:** Polson successfully reduced its **Borrowings** by **24.5%** year-on-year as of March 2024.
* **Profit Reinvestment:** The company maintains a policy of **ploughing back 100% of profits**; consequently, **no dividend** was recommended for the recent fiscal year.
* **Capital Structure:** Management utilizes a **Gearing Ratio** (Net Debt / Total Capital + Net Debt) to monitor and optimize the balance between equity and debt in response to economic shifts.
---
### **Risk Mitigation & Governance Framework**
Polson employs the **Polson Management System (PMS)** to identify and address risks, with oversight provided by the **Audit Committee**.
**Key Risk Factors:**
* **Market Volatility:** Exposure to global macroeconomic slowdowns (particularly in the **Eurozone**) and inflationary pressures on raw materials like **petrochemicals**.
* **Currency Exposure:** The company manages unhedged foreign currency exposure (USD) through forward contracts. As of March 2024, **Trade Receivables** in USD stood at **Rs. 690.78 Lakhs**.
* **Credit Risk:** The company manages extended credit periods for customers, ranging from **90 to 360 days**.
* **Regulatory & Compliance:** Ongoing efforts to align with **SEBI Regulation 17(1C)** regarding director regularization and **Regulation 46(2)** for digital transparency.
**Leadership Updates:**
To strengthen governance, **Mr. Youhaan Kapadia** was re-designated as **Executive Director** (May 2024), and **Ms. Alka Shashikant Dhuri** was appointed as **Non-Executive Woman Director** to ensure board diversity and regulatory compliance.